CD38 and HIV infectious disease: In contrast, a larger reduction in the proportion of CD4 + CD38 + HLA-DR+ T cells was found in late presenters than in individuals with primary HIV infection and early presenters, both after 6 and 12 months of follow-up (Fig. 1c).